TNYA
Tenaya Therapeutics Inc
0.5442$
+2.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | +393.3% | – | |
| – | – | – | – | – | +44.8% | +5.7% | +5.4% | +16.7% | +35.6% | +59.2% | +1.8% | +1.1% | +3.0% | +0.2% | +0.3% | -27.9% | -1.5% | – | – | – | – | -10.6% | -311.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -139.0% | – | – | |
| – | -4.6% | +21.9% | -1.4% | +14.7% | +13.7% | +18.7% | +61.9% | +15.3% | -13.6% | +13.8% | +8.4% | -0.6% | +3.4% | -12.8% | -1.0% | +9.6% | -9.6% | -10.2% | -8.2% | +12.8% | -17.6% | -11.6% | -3.7% | +0.3% | +11.9% | – | |
| – | -2.8% | +3.0% | -0.7% | +79.5% | +23.2% | +23.7% | -2.7% | +34.3% | +10.6% | -2.6% | +16.7% | -7.8% | +6.3% | -9.3% | +9.6% | +1.5% | -6.1% | -22.2% | -6.2% | +8.4% | +3.9% | -17.0% | +7.2% | -8.9% | -0.8% | – | |
| – | -4.3% | +17.8% | -1.2% | +20.3% | +14.7% | +21.1% | +45.3% | +19.2% | -10.0% | +6.1% | +11.2% | -2.7% | +4.2% | -13.0% | +1.8% | +11.1% | -9.2% | -6.9% | -7.7% | +11.7% | -20.1% | -4.8% | +18.1% | -25.1% | +144.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -99.6% | +124.2% | +168.5% | +54.4% | +347.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +208.9% | +0.2% | +5.9% | -2.4% | -28.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.